Ionis Pharma downgraded by BMO Capital Markets with a new price target

8/2/24 7:32:04 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

BMO Capital Markets downgraded Ionis Pharma from Outperform to Market Perform and set a new price target of $60.00 from $67.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$IONS

Date	Price Target	Rating	Analyst
4/7/2025	$45.00	Buy	H.C. Wainwright
3/31/2025	$39.00	Neutral	Redburn Atlantic
8/2/2024	$67.00 → $60.00	Outperform → Market Perform	BMO Capital Markets
7/24/2024	$53.00 → $62.00	Market Perform → Outperform	Leerink Partners
7/16/2024	$29.00 → $75.00	Buy	Jefferies
6/14/2024	$44.00	Underperform → Mkt Perform	Bernstein
4/10/2024	$58.00	Peer Perform → Outperform	Wolfe Research
1/2/2024	$52.00 → $62.00	Neutral → Buy	BofA Securities